Supportive Care

Increasing numbers of cancer treatment programs striving for improvements in efficiency and adherence to care look to nurses as a key element to improved patient outcomes.

This month's collection of trials in progress highlights trials presented at the 2011 American Society of Clinical Meeting.

Dr. Wayne Bardwell from the UCSD Cancer Center Discusses Psychosocial Needs of Cancer Patients

Dr. Teresa Woodruff from Feinberg School of Medicine, Northwestern University Discusses the Growing Field of Oncofertility

Oncology nursing and vascular access leaders provide their expert opinions to answer the question of whether a blood return needs be establised to administer non-vesicant chemotherapy.

Dr. Monica Morrow from Memorial Sloan-Kettering Cancer Center Discusses the Z11 Trial Focus on Morbidity

The investigational oral agent talactoferrin alfa reduces the risk of death in patients being treated in the intensive care unit for severe sepsis.

Dr. J. Michael Dixon from the University of Edinburgh on Advances in Breast Cancer Axillary Node Procedures

A new set of statistical models will soon be available to help predict the risk of lymphedema for patients with breast cancer who have undergone ALND.

The following is a roundup of TPS abstracts that feature trials open to patients aged >17 years with a broad range of cancer types.

A survey of more than 2200 physicians indicated that cancer specialists and primary care physicians (PCPs) differ markedly in their concerns about the care that cancer survivors receive.

A randomized trial comparing survivorship care plans with standard oncologist discharge visits in patients with breast cancer found no differences in outcomes among the groups.

Dr Jimmie C. Holland was long convinced that psychological status was a critical factor not just in cancer management, but in illness more broadly.

Oncologists too often fail to detect the severe distress that can accompany a diagnosis and subsequent treatment.

In the context of caring for cancer patients, all physicians and nurses trained in oncology receive education in quality-of-life issues; however, prolonging quantity of life remains our ultimate goal.

Donna Berry Describes the Electronic Self-Report Assessment for Cancer (ESRA-C) Program

Dr. Allen S. Lichter CEO of ASCO on the upcoming UN Summit for Non-Communicable Diseases

Karen Hagemaster from Advocate Good Samaritan Hospital on Chemotherapy Documentation Study

Dr. Sandhya Pruthi from the Mayo Clinic Explains the Flaxseed for Hot Flashes Trial Results

Dana Monroe from San Francisco Oncology Associates on Yervoy Side Effects and How Oncology Nurses Can Self-Educate

Dr. Lynn Schuchter from Penn Medicine Discusses Managing Ipilimumab's (Yervoy) Side Effects with the REMS program

FDA approvad Lazanda (fentanyl) nasal spray for the management of breakthrough pain in adult cancer patients.

Dr. Brian I. Rini from the Taussig Cancer Institute Describes Axitinib's and Sorafenib's Side Effects

Dr. David Cella from Northwestern University Feinberg School of Medicine on the Value of Patient-Reported Outcomes

A study published last week has identified new cancer risks for childhood cancer survivors.